文献速递重症综合管理与镇静镇痛心脑血管急症

SIRT1介导多微生物脓毒症小鼠模型中的脓毒性心肌病

SIRT1 Mediates Septic Cardiomyopathy in a Murine Model of Polymicrobial Sepsis.
PubMed 文献 · Shock · 2020-01-01
一句话结论小鼠脓毒症模型中,CLP后18小时给予SIRT1抑制剂EX-527可降低心脏SIRT1蛋白并改善整体纵向应变及纵向应变率,提示SIRT1可能是脓毒性心肌病的治疗靶点。

该研究先以脂多糖刺激离体H9c2心肌细胞,确认SIRT1 mRNA和蛋白在刺激后较晚时间点显著升高;随后采用盲肠结扎穿刺(CLP)C57BL/6小鼠模型,CLP后36小时心脏组织SIRT1 mRNA和蛋白较假手术对照升高。CLP后18小时给予选择性SIRT1抑制剂EX-527,可降低36小时心脏组织SIRT1蛋白表达,并改善心脏整体纵向应变和纵向应变率。作者结论认为,晚期脓毒症中重新平衡SIRT1过度表达可改善心脏性能,SIRT1可能作为脓毒性心肌病的治疗靶点。

要点

  • 离体H9c2心肌细胞经脂多糖刺激后,SIRT1 mRNA和蛋白水平在较晚时间点显著升高。
  • C57BL/6小鼠CLP后36小时,心脏组织SIRT1 mRNA和蛋白表达较假手术对照增加。
  • CLP后18小时给予选择性SIRT1抑制剂EX-527,可降低CLP后36小时心脏组织SIRT1蛋白表达。
  • EX-527治疗改善心脏性能,表现为整体纵向应变和纵向应变率增加。
  • 作者认为晚期脓毒症中重新平衡SIRT1过度表达可改善心脏性能,SIRT1可能作为脓毒性心肌病的治疗靶点。

适用人群与场景

  • 离体H9c2心肌细胞脂多糖刺激模型。
  • C57BL/6小鼠盲肠结扎穿刺(CLP)脓毒症模型,设假手术对照。

处置流程与药物剂量

  • CLP后18小时给予选择性SIRT1抑制剂EX-527,用于检测SIRT1在脓毒性心脏功能障碍中的作用;原文未写明EX-527的剂量、给药途径和疗程。

研究设计与关键结果

  • 研究类型:基础研究,包含离体细胞实验和小鼠在体实验;离体H9c2心肌细胞经脂多糖刺激后,SIRT1 mRNA和蛋白水平在较晚时间点显著升高。
  • C57BL/6小鼠CLP后36小时心脏组织SIRT1 mRNA和蛋白表达较假手术对照增加。
  • CLP后18小时给予EX-527,CLP后36小时心脏组织SIRT1蛋白表达降低。
  • EX-527治疗改善心脏性能,整体纵向应变和纵向应变率增加。

证据类型、等级与局限

  • 证据类型:基础研究(离体细胞实验和小鼠在体实验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,晚期脓毒症中重新平衡SIRT1过度表达可改善心脏性能,SIRT1可能作为脓毒性心肌病的治疗靶点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Cardiac dysfunction, a common complication from severe sepsis, is associated with increased morbidity and mortality. However, the molecular mechanisms of septic cardiac dysfunction are poorly understood. SIRT1, a member of the sirtuin family of NAD+-dependent protein deacetylases, is an important immunometabolic regulator of sepsis, and sustained SIRT1 elevation is associated with worse outcomes and organ dysfunction in severe sepsis. Herein, we explore the role of SIRT1 in septic cardiac dysfunction using a murine model of sepsis.

METHODS: An in vitro model of inflammation in isolated H9c2 cardiomyocytes was used to confirm SIRT1 response to stimulation with lipopolysaccharide (LPS), followed by a murine model of cecal ligation and puncture (CLP) to investigate the molecular and echocardiographic response to sepsis. A selective SIRT1 inhibitor, EX-527, was employed to test for SIRT1 participation in septic cardiac dysfunction.

RESULTS: SIRT1 mRNA and protein levels in cultured H9c2 cardiomyocytes were significantly elevated at later time points after stimulation with LPS. Similarly, cardiac tissue harvested from C57BL/6 mice 36 h after CLP demonstrated increased expression of SIRT1 mRNA and protein compared with sham controls. Administration of EX-527 18 h after CLP reduced SIRT1 protein expression in cardiac tissue at 36 h. Moreover, treatment with EX-527 improved cardiac performance with increased global longitudinal strain and longitudinal strain rate.

CONCLUSIONS: Our findings reveal that SIRT1 expression increases in isolated cardiomyocytes and cardiac tissue after sepsis inflammation. Moreover, rebalancing SIRT1 excess in late sepsis improves cardiac performance, suggesting that SIRT1 may serve as a therapeutic target for septic cardiomyopathy.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Smith LM, Yoza BK, Hoth JJ, et al. SIRT1 Mediates Septic Cardiomyopathy in a Murine Model of Polymicrobial Sepsis. Shock. 2020. PMID: 31393272. doi:10.1097/SHK.0000000000001429

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。